Cannabis Use and Risk of Acute Kidney Injury in Patients with Advanced Chronic Kidney Disease Transitioning to Dialysis [0.03%]
使用大麻与过渡到透析的晚期慢性肾病患者急性肾损伤的风险的关系研究
Praveen K Potukuchi,Hamid Moradi,Frank Park et al.
Praveen K Potukuchi et al.
Background: The current social and legal landscape is likely to foster the medicinal and recreational use of cannabis. Synthetic cannabinoid use is associated with acute kidney injury (AKI) in case reports; however, the association between ...
Observational Study
Cannabis and cannabinoid research. 2023 Feb;8(1):138-147. DOI:10.1089/can.2021.0044 2023
Microglial Cannabinoid Type 1 Receptor Regulates Brain Inflammation in a Sex-Specific Manner [0.03%]
小胶质细胞的大麻素1受体以性别特异性方式调节大脑炎症反应
Julia De Meij,Zain Alfanek,Lydie Morel et al.
Julia De Meij et al.
Background: Neuroinflammation is a key feature shared by most, if not all, neuropathologies. It involves complex biological processes that act as a protective mechanism to fight against the injurious stimuli, but it can lead to tissue damag...
Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms [0.03%]
以大麻酚为主的大麻制剂使用者问卷调查：感知的医疗效果，不良事件和戒断症状
Ethan B Russo,Carrie Cuttler,Ziva D Cooper et al.
Ethan B Russo et al.
Introduction: Cannabigerol (CBG), and its precursor before decarboxylation, cannabigerolic acid is sometimes labeled the "mother of all cannabinoids." The purpose of the present study was to investigate reasons for use and self-reported the...
Crist N Filer
Crist N Filer
Introduction:Cannabis is a valuable plant, cultivated by humans for millennia. However, it has only been in the past several decades that biologists have begun to clarify the interesting Cannabis biosynthesis details, especially the product...
Jamie Corroon
Jamie Corroon
In recent years, marketers of cannabis (i.e., marijuana) products have claimed that cannabinol (CBN) has unique sleep-promoting effects. Despite a plausible mechanism, it is possible that such claims are merely rooted in cannabis lore. The ...
Phenotypic Characterization of the Endocannabinoid-Degrading Enzyme Alpha/Beta-Hydrolase Domain 6 Knockout Rat [0.03%]
ABHD6基因敲除大鼠的表型特征研究
Katsuhiko Noguchi,Katsumi Kadekawa,Saori Nishijima et al.
Katsuhiko Noguchi et al.
Introduction: Alpha/beta-hydrolase domain 6 (ABHD6) is an enzyme that hydrolyzes 2-arachidonoylglycerol, a high-efficiency endogenous cannabinoid. Although the endocannabinoid system has been suggested to be involved in regulation of bladde...
Daniel J Kruger,Majd A Mokbel,Daniel J Clauw et al.
Daniel J Kruger et al.
Introduction: Many health care providers would benefit from greater knowledge and awareness of medical cannabis, even if they choose not to integrate it into their medical practice. Unfortunately, health care providers generally report low ...
Safety and Efficacy of Medical Cannabis in Autism Spectrum Disorder Compared with Commonly Used Medications [0.03%]
自闭症谱系障碍患者使用医用大麻的安全性和有效性的系统评价和荟萃分析及其与常用药物的比较
Richard Holdman,Daniel Vigil,Kelsey Robinson et al.
Richard Holdman et al.
Objective: The objective of this study was to evaluate the safety and efficacy of medications commonly used in autism spectrum disorder (ASD) and compare this to what current research has shown regarding medical cannabis use in this populat...
Observational Study
Cannabis and cannabinoid research. 2022 Aug;7(4):451-463. DOI:10.1089/can.2020.0154 2022
Preliminary Eye-Tracking Data as a Nonintrusive Marker for Blood Δ-9-Tetrahydrocannabinol Concentration and Drugged Driving [0.03%]
眼动追踪数据作为血液中Δ-9-四氢大麻酚浓度和吸毒驾驶的非侵入式标志的初步证据
Ali Shahidi Zandi,Felix J E Comeau,Robert E Mann et al.
Ali Shahidi Zandi et al.
Background: Cannabis is one of the drugs most often found in drivers involved in serious motor vehicle collisions. Validity and reliability of roadside cannabis detection strategies are questioned. This pilot study aimed to investigate the ...
Ask Your Provider About Cannabis: Increasing Nurse Practitioner Knowledge and Confidence [0.03%]
向您的医生咨询大麻：增加执业护士的知识和信心
Tracy A Klein,Ross Bindler
Tracy A Klein
Introduction: Nurse practitioners (NPs) are authorizing providers for medical cannabis in many states, and may serve as a primary care clinician. We report findings from a nationally distributed 2-h continuing education (CE) module aimed to...